Most people tolerate a 1000 mg dose well, but there are a few things to keep in mind
These findings suggest ipamorelin could aid in developing type 2 diabetes therapies by boosting insulin secretion
This talk will feature the following research faculty: Aaron Gabryluk, Research Scientist, IPaT Brian Jones, Principal Research Engineer, IPaT Richard Starr, Director of Research Operations and Research Scientist, IPaT Scott Gilliland, Senior Research Scientist, IPaT The New Shriners Childrens Research Institute Leanne West, Principal Research Scientist and Chief Engineer of Pediatric Technologies, Georgia Tech Nov 13, 2025 12:00 p.m
Or, more to the point, what can be done about them
Starting at a low dose and titrating slowly allows your body to adapt and helps distinguish between expected GLP-1 side effects and genuine medication intolerance
Cockerill et al., 2018)